Good article. Summary of what most of us already know; now it's summarized with $20m behind it and out there to help educate others on the sideline or in the dark. Next PR should be more substantial regarding clinical data...they were tee'd up waiting for funding, so as soon as the transaction closes and they can execute some of the logistics, we should see some action.